scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2: a storm is raging.

Savannah F. Pedersen, +1 more
- 01 May 2020 - 
- Vol. 130, Iss: 5, pp 2202-2205
TLDR
Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design and the authors found that respiratory distress on admission is associated with unfavorable outcomes.
Abstract
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunological characteristics between moderate and severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.

read more

Citations
More filters
Journal ArticleDOI

Molecular mechanisms and therapeutic target of NETosis in diseases

TL;DR: Evidence shows that neutrophils can protect the host against pathogens in multiple ways, including the formation and release of neutrophil extracellular traps (NETs), and researchers have discovered that several NET inhibitors, such as toll‐like receptor inhibitors and reactive oxygen species scavengers, can prevent uncontrolled NET development.
Journal ArticleDOI

Immunological Interfaces: The COVID-19 Pandemic and Depression

TL;DR: There is a critical and time-sensitive need to better understand immune interfaces between depression and COVID-19, and associated immunological perturbations favoring a pro-inflammatory state could underlie an increased risk for depressive symptomatology.
Posted ContentDOI

Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye

TL;DR: The bioactivity of these lipid mediators will contribute to opening therapeutic avenues for COVID-19 by counteracting virus attachment and entrance to the eye and other cells and the ensuing disruptions of homeostasis.
Journal ArticleDOI

The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction.

TL;DR: Immunoprophylactic and immunomodulatory strategies are recommended for the different strata of stakeholders combating the pandemic with the hope that morbidities and mortalities associated with COVID-19 would be drastically reduced.
Journal ArticleDOI

Иммунопатология и иммунофармакотерапия коронавирусной болезни 2019 (COVID-19): фокус на интерлейкин 6

E. L. Nasonov
TL;DR: Data is discussed on the clinical and prognostic value of IL-6 and the effectiveness of anti-IL-6 receptor and anti-il-6 mAbs, as well as prospects for personalized therapy of the cytokine storm syndrome in COVID-19.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Related Papers (5)